← Back to all trials
Active Not Recruiting
NCT07619443
A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
Conditions: Healthy
Sex: All
Ages: 19 Years – 55 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 30
Sponsor: Merck Sharp & Dohme LLC
Location: Celerion ( Site 0001) Lincoln Nebraska
Summary
The goal of this study is to learn what happens to a single dose of enlicitide over time in a healthy participant's body when the participant is given a single dose of MK-7262 and what happens to a single dose of MK-7262 over time in a healthy participant's body when the participant is given a single dose of enlicitide.
Eligibility Criteria
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
* Is in good health before randomization
* Has a body mass index (BMI) ≥18 and ≤32 kg/m\^2, inclusive
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
* Has a history or presence of clinically significant medical or psychiatric condition or disease
* Has a history of cancer
Source: ClinicalTrials.gov (NCT07619443). StuddyBuddy aggregates publicly available trial information.
